In the cover story of the latest issue of Life Sciences Platform, “Biotechnology 2017”, Dr. Thiel gives an overview of the development of the life science industry in the current year.

Many doubts were raised trough electioneering in the US in 2016,  but meanwhile the optimism in the growth of the life science market is back. Amongst other things, the end of the discussion about a regulation of drug pricing in the US and the abandon of plans for a health care and corporate tax reform, resulted in positive impulses at the stock exchange.

You can read the whole article here→  (German-language link)